Health Wire Taiwan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Taiwan.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on December 4, 2025

Dec. 4, 2025

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 4, 2025

MEDIROM Mother Labs Partners with TD SYNNEX to Accelerate National Adoption of "MOTHER Bracelet" and "REMONY"

GlobeNewswire

Dec. 4, 2025

Grunt Style Foundation Submits Testimony to Senate Veterans Affairs Committee

GlobeNewswire

Dec. 4, 2025

Aveanna to Participate at the BofA Securities Home Care Conference

GlobeNewswire

Dec. 4, 2025

CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies

GlobeNewswire

Dec. 4, 2025

Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation

GlobeNewswire

Dec. 4, 2025

Healthy Habits Made Easy: Update Your Pet’s Health and Wellness Routine Without Fuss

GlobeNewswire

Dec. 4, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 4, 2025

CooperCompanies Announces New Chair of the Board and Strategic Review

GlobeNewswire

Dec. 4, 2025

Protara Announces Proposed Public Offering

GlobeNewswire

Dec. 4, 2025

CooperCompanies Announces Fourth Quarter and Full Year 2025 Results

GlobeNewswire

Dec. 4, 2025

Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies

GlobeNewswire

Dec. 4, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 4, 2025

TOMI Environmental Solutions to Present at the 2025 Sidoti Year End Investor Conference

GlobeNewswire

Dec. 4, 2025

ImPact Biotech Presents Updated Preliminary Data from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at SUO 2025

GlobeNewswire

Dec. 4, 2025

Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor

GlobeNewswire

Dec. 4, 2025

GATC Health to Host Virtual KOL Event to Discuss Derisq™ AI Report: Predictive, Detailed Risk Assessment of Drug Candidates, on December 10, 2025

GlobeNewswire

Dec. 4, 2025

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

Dec. 4, 2025

Latest Legal Anabolic Steroid Alternatives for Bodybuilding 2026: Natural Steroids for Muscle Building & Cutting Fat Introduced by CrazyBulk

GlobeNewswire

Dec. 4, 2025

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

GlobeNewswire